...
首页> 外文期刊>Diabetes/metabolism research and reviews >Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34).
【24h】

Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34).

机译:在亚洲印第安人中使用WHO,ATPIII和IDF定义进行代谢综合征的流行:《钦奈城市农村流行病学研究》(CURES-34)。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To compare the prevalence of metabolic syndrome (MS) using the World Health Organisation (WHO), Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF) criteria of MS in an urban south Indian population, and their ability to identify coronary artery disease (CAD) in males and females. METHODS: Chennai Urban Rural Epidemiology Study (CURES) is one of the largest epidemiological studies on diabetes carried out in India, in which 26 001 individuals aged >or=20 years were screened using systematic random sampling method. Every tenth subject recruited in Phase 1 of CURES was requested to participate in Phase 3, and the response rate was 90.4%. An oral glucose tolerance test (OGTT) was performed in all individuals except self-reported diabetic subjects. Anthropometric measurements and lipid estimations were done in all subjects and the prevalence of MS estimated using the three criteria. Diagnosis of CAD, made by resting 12 lead ECG, was compared by the three criteria of MS. RESULTS: MS was identified in 546 subjects (23.2%) by WHO criteria, 430 subjects (18.3%) by ATPIII criteria and 607 subjects (25.8%) by IDF criteria. Only 224 of these subjects were identified by all the three criteria. There was an increased risk of probable CAD in MS subjects diagnosed by WHO criteria (odds ratio (OR) 3.86, 95% Confidence Interval (CI), 2.37-6.29, p < 0.001), compared to ATPIII criteria (OR 2.19, 95% CI 1.30-3.67, p < 0.05) and IDF criteria (OR 1.90, 95% CI 1.16-3.12, p < 0.05). The WHO criteria marked out a much higher population for CAD risk compared to ATPIII and IDF criteria in males, but not in females. CONCLUSION: In Asian Indians, the WHO, ATPIII and IDF criteria of MS identify different individuals. The WHO criteria identify a greater number of CAD subjects in males, but not in females.
机译:目的:使用世界卫生组织(WHO),成人治疗小组III(ATPIII)和国际糖尿病联合会(IDF)的标准,比较印度南部城市南部人群的代谢综合征(MS)患病率及其识别能力男性和女性冠状动脉疾病(CAD)。方法:钦奈城市农村流行病学研究(CURES)是印度进行的最大的糖尿病流行病学研究之一,其中使用系统随机抽样方法筛选了26 001名≥20岁的个体。 CURES第1阶段招募的每10名受试者都被要求参加第3阶段,回应率为90.4%。除自我报告的糖尿病受试者外,所有个体均进行了口服葡萄糖耐量试验(OGTT)。在所有受试者中进行人体测量和脂质估算,并使用这三个标准估算MS的患病率。静息12导联心电图对CAD的诊断与MS的三个标准进行了比较。结果:根据WHO标准,在546名受试者(23.2%),根据ATPIII标准的430名受试者(18.3%)和根据IDF标准的607名受试者(25.8%)中鉴定出了MS。所有这三个标准仅识别了这些受试者中的224名。与ATPIII标准(OR 2.19,95%)相比,通过WHO标准诊断的MS受试者中可能的CAD风险增加(优势比(OR)3.86,95%置信区间(CI),2.37-6.29,p <0.001) CI 1.30-3.67,P <0.05)和IDF标准(OR 1.90,95%CI 1.16-3.12,P <0.05)。与ATPIII和IDF标准相比,WHO标准在CAD人群中有较高的CAD风险人群,而男性则没有。结论:在亚洲印第安人中,MS的WHO,ATPIII和IDF标准可以识别不同的个体。 WHO的标准确定了更多的CAD对象是男性,而不是女性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号